应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01177 中国生物制药
未开盘 12-23 16:08:09
6.450
-0.090
-1.38%
最高
6.600
最低
6.420
成交量
3,556万
今开
6.560
昨收
6.540
日振幅
2.75%
总市值
1,210亿
流通市值
1,210亿
总股本
187.61亿
成交额
2.30亿
换手率
0.19%
流通股本
187.61亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
热搜第一!“进口抗癌假药”1500元一盒,有效成分却为0
中国基金报 · 12-22 21:27
热搜第一!“进口抗癌假药”1500元一盒,有效成分却为0
每日卖空追踪 | 中国生物制药 12月22日卖空量成交281万股,卖空比例为9.27%
市场透视 · 12-22 16:30
每日卖空追踪 | 中国生物制药 12月22日卖空量成交281万股,卖空比例为9.27%
中国生物制药12月22日遭主力抛售46.0万元
市场透视 · 12-22 16:15
中国生物制药12月22日遭主力抛售46.0万元
中国生物制药谢炘:创新药领域未来还会有更多的并购出现
钛媒体快报 · 12-19
中国生物制药谢炘:创新药领域未来还会有更多的并购出现
每日卖空追踪 | 中国生物制药 12月19日卖空量成交378万股,卖空比例为7.06%
市场透视 · 12-19
每日卖空追踪 | 中国生物制药 12月19日卖空量成交378万股,卖空比例为7.06%
每日卖空追踪 | 中国生物制药 12月18日卖空量成交521.8万股,卖空比例为9.2%
市场透视 · 12-18
每日卖空追踪 | 中国生物制药 12月18日卖空量成交521.8万股,卖空比例为9.2%
中国生物制药12月18日主力净流入1634.9万元 散户资金抛售
市场透视 · 12-18
中国生物制药12月18日主力净流入1634.9万元 散户资金抛售
每日卖空追踪 | 中国生物制药 12月16日卖空量成交530.6万股,卖空比例为9.4%
市场透视 · 12-16
每日卖空追踪 | 中国生物制药 12月16日卖空量成交530.6万股,卖空比例为9.4%
东方财富证券:创新浪潮涌动下 关注医药板块修复与突破
智通财经 · 12-16
东方财富证券:创新浪潮涌动下 关注医药板块修复与突破
医药行业周报:IN VIVO CART:BD热门赛道 早期技术具备广阔前景
中信建投证券 · 12-14
医药行业周报:IN VIVO CART:BD热门赛道 早期技术具备广阔前景
中国生物制药(01177):库莫西利胶囊获批上市
智通财经 · 12-12
中国生物制药(01177):库莫西利胶囊获批上市
每日卖空追踪 | 中国生物制药 12月12日卖空量成交262.3万股,卖空比例为4.64%
市场透视 · 12-12
每日卖空追踪 | 中国生物制药 12月12日卖空量成交262.3万股,卖空比例为4.64%
【券商聚焦】交银国际:创新药增量支付空间持续扩大
金吾财讯 · 12-12
【券商聚焦】交银国际:创新药增量支付空间持续扩大
港股早知道 | 国际银价续创新高;汇丰:预计美联储明后两年不会降息;云顶新耀与海森生物达成战略合作
智通财经 · 12-12
港股早知道 | 国际银价续创新高;汇丰:预计美联储明后两年不会降息;云顶新耀与海森生物达成战略合作
中国生物制药12月11日主力净流出1010.4万元 散户资金买入
市场透视 · 12-11
中国生物制药12月11日主力净流出1010.4万元 散户资金买入
每日卖空追踪 | 中国生物制药 12月10日卖空量成交456.3万股,卖空比例为9.14%
市场透视 · 12-10
每日卖空追踪 | 中国生物制药 12月10日卖空量成交456.3万股,卖空比例为9.14%
交银国际:医保商保目录落地 多元支付体系创新药增量空间
智通财经 · 12-10
交银国际:医保商保目录落地 多元支付体系创新药增量空间
招银国际:2025医保目录公布延续支持创新 料CXO业下半年修复
智通财经 · 12-09
招银国际:2025医保目录公布延续支持创新 料CXO业下半年修复
【券商聚焦】交银国际:2025年医保+商保双目录落地 多元支付体系盘活创新药增量空间
金吾财讯 · 12-09
【券商聚焦】交银国际:2025年医保+商保双目录落地 多元支付体系盘活创新药增量空间
每日卖空追踪 | 中国生物制药 12月08日卖空量成交418.9万股,卖空比例为6.54%
市场透视 · 12-08
每日卖空追踪 | 中国生物制药 12月08日卖空量成交418.9万股,卖空比例为6.54%
加载更多
公司概况
公司名称:
中国生物制药
所属市场:
SEHK
上市日期:
--
主营业务:
中国生物制药有限公司是一家主要从事制药业务的投资控股公司。该公司通过三个分部运营。中药现代制剂及西药分部主要从事生产、销售及配销中药现代制剂及西药产品业务。投资分部主要从事长期投资业务。其他分部主要从事相关医疗及医院业务。
发行价格:
--
{"stockData":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"中国生物制药","latestPrice":6.45,"timestamp":1766477289002,"preClose":6.54,"halted":0,"volume":35560940,"delay":0,"floatShares":18761000000,"shares":18761000000,"eps":0.21201407030915811,"marketStatus":"未开盘","change":-0.09,"latestTime":"12-23 16:08:09","open":6.56,"high":6.6,"low":6.42,"amount":230467227,"amplitude":0.027523,"askPrice":6.45,"askSize":160000,"bidPrice":6.44,"bidSize":223000,"shortable":3,"etf":0,"ttmEps":0.2369628342057165,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":0,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":6.54,"dividendRate":0.014218,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":0.7049574441180166,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.3605,"impliedVolPercentile":0.1382},"requestUrl":"/m/hq/s/01177","defaultTab":"news","newsList":[{"id":"2593804455","title":"热搜第一!“进口抗癌假药”1500元一盒,有效成分却为0","url":"https://stock-news.laohu8.com/highlight/detail?id=2593804455","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593804455?lang=zh_cn&edition=full","pubTime":"2025-12-22 21:27","pubTimestamp":1766410055,"startTime":"0","endTime":"0","summary":"经检测发现,该版本药品中安罗替尼的含量为0,即“境外版”安罗替尼本质上是完全没有有效成分的假药。该药物在国内流通后,因下游层层加价,一般患者购买的价格在1500元左右一盒,每盒的药量是正版的三倍。公安机关将患者家属提供的剩余药品送至鉴定机构检测,鉴定结论和上述药企的结论一致,即该安罗替尼“仿制药”中未检出安罗替尼成分。由此,连云港市市场监督管理局认定,涉案相关药品可以认定为假药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230225a46afb02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222230225a46afb02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1521","BK1191","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1589","SBHMY","01177"],"gpt_icon":0},{"id":"2593333455","title":"每日卖空追踪 | 中国生物制药 12月22日卖空量成交281万股,卖空比例为9.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593333455","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593333455?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392219,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月22日,跌0.46%,卖空量成交281万股,较上一交易日减少69.39%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163253a4699359&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163253a4699359&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","01177","BK1521","IE00BZ08YT58.USD","BK1589","BK1191","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1515"],"gpt_icon":0},{"id":"2593455870","title":"中国生物制药12月22日遭主力抛售46.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593455870","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593455870?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391309,"startTime":"0","endTime":"0","summary":"12月22日, 中国生物制药股价跌0.46%,报收6.54元,成交金额2.2亿元,换手率0.18%,振幅2.59%,量比0.53。中国生物制药今日主力资金净流出46.0万元,上一交易日主力净流出2054.2万元。该股近5个交易日上涨1.85%,主力资金累计净流出286.5万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入1451.6万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161520a6c0842c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161520a6c0842c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","01177","BK1521","IE00BZ08YT58.USD","BK1589","BK1191","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1515"],"gpt_icon":0},{"id":"2592911923","title":"中国生物制药谢炘:创新药领域未来还会有更多的并购出现","url":"https://stock-news.laohu8.com/highlight/detail?id=2592911923","media":"钛媒体快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592911923?lang=zh_cn&edition=full","pubTime":"2025-12-19 17:48","pubTimestamp":1766137688,"startTime":"0","endTime":"0","summary":"钛媒体App 12月19日消息,钛媒体集团 2025 T-EDGE 12月8日-12月21日全球同步开启。会上,中国生物制药执行董事、资深副总裁谢炘表示,创新药领域未来还会有更多的并购出现,因为企业间的融合并购是社会化分工的必然,让研发强的做研发、销售强的做销售,才能实现效率最大化、成本最低化,形成 1+1>2 的协同效应。同时,通过并购重组也能增强出海的竞争能力。(2025 T-EDGE)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219175016a45f8958&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219175016a45f8958&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1589","BK1574","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","06978","BK1521","BK1515","01177","BK1191","BK1161"],"gpt_icon":0},{"id":"2592913231","title":"每日卖空追踪 | 中国生物制药 12月19日卖空量成交378万股,卖空比例为7.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592913231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592913231?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133019,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月19日,涨1.23%,卖空量成交378万股,较上一交易日减少65.05%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163249a45f33ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163249a45f33ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1191","BK1521","HK0000165453.HKD","IE00BZ08YT58.USD","01177","BK1515","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2592999908","title":"每日卖空追踪 | 中国生物制药 12月18日卖空量成交521.8万股,卖空比例为9.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592999908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592999908?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046618,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月18日,涨0.78%,卖空量成交521.8万股,较上一交易日减少61.95%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163232a45aa04a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163232a45aa04a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YR35.GBP","BK1521","IE00BZ08YT58.USD","01177","IE00BZ08YS42.EUR","HK0000165453.HKD","BK1515","BK1589","BK1191"],"gpt_icon":0},{"id":"2592588021","title":"中国生物制药12月18日主力净流入1634.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592588021","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592588021?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:15","pubTimestamp":1766045748,"startTime":"0","endTime":"0","summary":"12月18日, 中国生物制药股价涨0.78%,报收6.49元,成交金额3.7亿元,换手率0.30%,振幅3.26%,量比0.90。中国生物制药今日主力资金净流入1634.9万元,上一交易日主力净流出636.1万元。该股近5个交易日下跌2.82%,主力资金累计净流出444.2万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入5428.4万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218162056a6b1a268&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218162056a6b1a268&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","IE00BZ08YT58.USD","01177","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1589","BK1521","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2592552789","title":"每日卖空追踪 | 中国生物制药 12月16日卖空量成交530.6万股,卖空比例为9.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592552789","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592552789?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873818,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月16日,跌0.62%,卖空量成交530.6万股,较上一交易日减少68.94%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163243a6a8b47d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163243a6a8b47d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","IE00BZ08YT58.USD","01177","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1589","BK1521","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2591022646","title":"东方财富证券:创新浪潮涌动下 关注医药板块修复与突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2591022646","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591022646?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:25","pubTimestamp":1765873557,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,东方财富证券发布研报称,随着中国创新药License-out项目总金额创下新纪录,临床前项目占比持续保持高位,ADC、双/多抗、小核酸等新兴疗法,以及代谢领域中肥胖适应症等或为未来License-out项目的重点方向。东方财富证券主要观点如下:今年以来,在创新药、AI医疗的带动下,化学制药板块领涨医药板块估值水平接近最近10年历史平均水平。中国创新药十年变革主要得益于全面的监管改革、研发投入的增加以及战略性的全球化布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2148510915.USD","LU1064131003.USD","LU1969619763.USD","LU2495084118.USD","BK0196","LU1831875114.USD","09939","BK1589","LU2097828557.USD","BK0028","300059","SG9999014674.SGD","LU2543165471.USD","LU1303224171.USD","LU1770034418.SGD","LU1997244956.HKD","161027","LU0326950275.SGD","BK0095","BK1515","LU0588546209.SGD","LU1251922891.USD","BK1500","LU2097828714.EUR","LU1997245177.USD","LU0307460666.USD","159938","BK1583","IE00BZ08YS42.EUR","01177","LU2097828631.EUR","HK0000165453.HKD","BK1521","BK0188","06160","01276","LU2328871848.SGD","LU2580892789.USD","BK1191","BK1588","LU1719994722.HKD","LU2097828474.EUR","IE00BZ08YR35.GBP","LU0359202008.SGD","IE00BZ08YT58.USD","BK0077","LU2289578879.USD","BK1574","LU2097828805.USD"],"gpt_icon":0},{"id":"2591657917","title":"医药行业周报:IN VIVO CART:BD热门赛道 早期技术具备广阔前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2591657917","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591657917?lang=zh_cn&edition=full","pubTime":"2025-12-14 00:00","pubTimestamp":1765641600,"startTime":"0","endTime":"0","summary":"核心观点:In Vivo CART赛道发展火热,2025年已经有四个MNC并购的案例发生。具体来看,In Vivo CART分为LNP和慢病毒两条技术路线,两条技术路线均具备显著特色。LNP路线来看,药物在临床前展现出了快速转染以及优异的靶向性特点,慢病毒路线中,Esobiotec等公司的BCMA In Vivo CART已经在小人群MM患者中展现非常好的早期数据。整体看,In VivoCART发展迅速,后续发展值得关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214150229a4496027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU1046422090.SGD","01177","BK1574","LU2242644610.SGD","BK1161","06160","01801","LU0052750758.USD","06978","LU0708995583.HKD","06821","BK1576","LU2125910500.SGD","LU2045819591.USD","BK1141","LU0320764599.SGD","02359"],"gpt_icon":0},{"id":"2590657123","title":"中国生物制药(01177):库莫西利胶囊获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2590657123","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590657123?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:54","pubTimestamp":1765529678,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国生物制药 公布,集团自主研发的国家1类创新药库莫西利胶囊 已获得中国国家药品监督管理局 的上市批准,用于与氟维司群联合治疗既往接受内分泌治疗后出现疾病进展的激素受体 阳性、人表皮生长因子受体2 阴性的局部晚期或转移性乳腺癌患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国生物制药(01177):库莫西利胶囊获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","IE00BZ08YR35.GBP","HK0000165453.HKD","BK1515","BK1589","BK1521","01177"],"gpt_icon":0},{"id":"2591382066","title":"每日卖空追踪 | 中国生物制药 12月12日卖空量成交262.3万股,卖空比例为4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591382066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591382066?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528218,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月12日,涨1.04%,卖空量成交262.3万股,较上一交易日减少68.29%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165237a4446a2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165237a4446a2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","HK0000165453.HKD","IE00BZ08YT58.USD","BK1521","BK1515","IE00BZ08YS42.EUR","01177","BK1191","IE00BZ08YR35.GBP"],"gpt_icon":0},{"id":"2590233595","title":"【券商聚焦】交银国际:创新药增量支付空间持续扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2590233595","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590233595?lang=zh_cn&edition=full","pubTime":"2025-12-12 09:02","pubTimestamp":1765501348,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示,10月以来,内资通过港股通持有医药股的比例小幅下降,外资持仓整体平稳,内外资加大创新药布局的大方向不变。该机构指,本周医保+商保双目录落地,医保谈判新增品种成功率创近年新高,续约品种降价幅度相对温和。该机构认为商保资金的引入将为创新药支付带来重要增量资金,进一步优化多元支付体系。该机构看好医保新纳入品种/适应症在2026年的销售放量,以及首版商保目录的实际执行和支付情况。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971425","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU2097828714.EUR","BK1588","SG9999002463.SGD","LU0634319403.HKD","LU0181495838.USD","01877","LU0043850808.USD","06978","09688","BK1161","03329","LU2242644610.SGD","LU0540923850.HKD","LU2097828631.EUR","LU1794554557.SGD","LU0359201612.USD","LU0502904849.HKD","LU2039709279.SGD","LU2778985437.USD","09995","LU0359202008.SGD","06160","01801","LU2328871848.SGD","LU1242518931.SGD","159992","LU0417516738.SGD","LU2097828557.USD","LU1961090484.USD","LU1969619763.USD","LU1770034418.SGD","01177","LU1993786604.SGD","LU0880133367.SGD","LU1951186391.HKD","01093","02269","09926","LU1226287529.USD","02616","LU0516423091.SGD","HK0000165453.HKD","02142","SG9999004220.SGD","IE00B0JY6N72.USD","LU0067412154.USD","LU0708995583.HKD","06185","LU0456827905.SGD"],"gpt_icon":0},{"id":"2590475925","title":"港股早知道 | 国际银价续创新高;汇丰:预计美联储明后两年不会降息;云顶新耀与海森生物达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2590475925","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590475925?lang=zh_cn&edition=full","pubTime":"2025-12-12 09:00","pubTimestamp":1765501238,"startTime":"0","endTime":"0","summary":"此前美联储政策制定者以分化的表决结果将利率下调了25个基点。云顶新耀宣布与海森生物达成战略合作,发挥商业化平台的优势与布局2025年12月11日,港股创新药企云顶新耀宣布,其全资附属公司云顶新耀医药科技有限公司已与海森生物医药有限公司签署两项战略合作协议:商业化服务协议以及授权许可协议。本次增持后,朱江明及傅利泉与所属的单一最大股东集团合共持有公司2.09亿股H股及1.29亿股内资股,占公司已发行总股数的23.75%。","market":"hk","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380662.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09863","IE00BZ08YT58.USD","BK1574","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1583","06099","BK1147","01177","BK1521","BK1161","02670","BK1589","BK1191","BK1183","BK1564","09969","BK1119","BK1515","IE00BZ08YS42.EUR","01952"],"gpt_icon":0},{"id":"2590523693","title":"中国生物制药12月11日主力净流出1010.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590523693","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590523693?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440905,"startTime":"0","endTime":"0","summary":"12月11日, 中国生物制药股价跌0.59%,报收6.73元,成交金额3.7亿元,换手率0.29%,振幅2.95%,量比0.96。中国生物制药今日主力资金净流出1010.4万元,上一交易日主力净流入2431.3万元。该股近5个交易日下跌1.45%,主力资金累计净流出1034.3万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入6392.5万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211161530a6990888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211161530a6990888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","01177","HK0000165453.HKD","BK1191","BK1521","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1515","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2590807575","title":"每日卖空追踪 | 中国生物制药 12月10日卖空量成交456.3万股,卖空比例为9.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590807575","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590807575?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355419,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月10日,跌1.46%,卖空量成交456.3万股,较上一交易日减少68.4%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016325395353c64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016325395353c64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YS42.EUR","HK0000165453.HKD","BK1521","IE00BZ08YR35.GBP","01177","BK1191","IE00BZ08YT58.USD","BK1515","BK1589"],"gpt_icon":0},{"id":"2590305967","title":"交银国际:医保商保目录落地 多元支付体系创新药增量空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2590305967","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590305967?lang=zh_cn&edition=full","pubTime":"2025-12-10 14:26","pubTimestamp":1765348009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,交银国际发布研报称,予内地医药行业领先评级。国家医保局召开“2025年创新药高质量发展大会”,正式公布本轮医保谈判和商保创新药目录协商结果。同时,商保资金的引入将为创新药支付带来重要增量资金,未来商业健康险有望与基本医保错位发展,为多元化支付体系的建立奠定基础。该行看好新纳入品种/适应症在2026年的销售增长潜力,尤其是康方生物等潜在大单品的增量释放空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0502904849.HKD","BK1574","IE00BPRC5H50.USD","LU0359201612.USD","LU2242644610.SGD","LU0348827113.USD","IE00B5MMRT66.SGD","BK1147","LU1961090484.USD","BK1589","LU0348767384.USD","HK0000165453.HKD","LU0348825331.USD","09926","LU0348735423.USD","LU0561508036.HKD","LU2778985437.USD","LU2488822045.USD","LU1969619763.USD","01801","159992","01177","LU2097828631.EUR","LU0417516902.SGD","LU2097828557.USD","LU0359202008.SGD","01276","BK1191","LU0417516738.SGD","BK1521","LU0348766576.USD","LU2097828714.EUR","BK1583","BK1515","LU2476274308.USD","BK1161","03329","IE00BZ08YS42.EUR","LU2097828805.USD","LU2328871848.SGD","LU0540923850.HKD","IE00B543WZ88.USD","LU0634319403.HKD","06978","LU0359201885.HKD","LU0417516571.SGD","LU0348783233.USD","LU2399975544.HKD","LU2097828474.EUR","LU0348784397.USD"],"gpt_icon":0},{"id":"2590393913","title":"招银国际:2025医保目录公布延续支持创新 料CXO业下半年修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2590393913","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590393913?lang=zh_cn&edition=full","pubTime":"2025-12-09 10:03","pubTimestamp":1765245827,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,招银国际发布研报称,2025年版基本医保目录以及首版商保目录发布,延续支持创新,料CXO行业有望在下半年迎来业绩修复。推荐买入三生制药(01530)、固生堂(02273)、药明合联(02268)、巨子生物(02367)、信达生物(01801)、中国生物制药(01177)。报告表示,多家企业的核心创新品种获纳入医保。该行认为,宏观环境及老龄化的挑战下,医保收支压力仍在,关注国家集采续约。尽管首版商保目录短期对于产品销售的拉动有限,由于商业保险的规模不大,认为商保目录的意义重大,或将开启中国商业医疗保险扩容的道路,成为中国多元化支付体系发展开端。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999004311.SGD","LU2097828714.EUR","LU2488822045.USD","CXO","SG9999014674.SGD","BK1207","BK1589","BK1161","LU2242644610.SGD","LU2097828631.EUR","02268","LU0455707207.USD","LU2097828474.EUR","LU0502904849.HKD","BK1521","02367","01801","LU2328871848.SGD","BK1515","IE00BZ08YR35.GBP","BK1219","LU2097828557.USD","LU1969619763.USD","IE00BZ08YS42.EUR","BK1191","01177","02273","BK1583","BK1141","HK0000165453.HKD","BK1593","IE00BZ08YT58.USD","LU2097828805.USD","01530"],"gpt_icon":0},{"id":"2590367035","title":"【券商聚焦】交银国际:2025年医保+商保双目录落地 多元支付体系盘活创新药增量空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2590367035","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590367035?lang=zh_cn&edition=full","pubTime":"2025-12-09 08:59","pubTimestamp":1765241994,"startTime":"0","endTime":"0","summary":"调整后的目录中,药品总数增至3,253种。新版目录将于2026年1月1日正式实施。该机构认为,更多新药进入目录有助于提升临床用药水平,及创新药行业整体研发回报率;商保资金的引入将为创新药支付带来重要增量资金,为多元化支付体系的建立奠定基础。百济有两款产品纳入商保创新药目录,信达、和黄各有一款纳入。同时重点关注首批商保目录的实际执行和支付情况、名单及定价的动态调整以及真实世界数据积累带来的长期发展机会。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971149","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348783233.USD","LU0417516902.SGD","LU1226288170.HKD","09995","LU0348767384.USD","LU0880133367.SGD","IE00BZ08YR35.GBP","BK1576","LU0348766576.USD","LU0516423091.SGD","06185","LU0327786744.USD","LU1813983027.USD","LU0708995583.HKD","BK1574","LU0181495838.USD","LU0456827905.SGD","LU1719994722.HKD","LU2399975544.HKD","LU1720050803.USD","LU1770034418.SGD","LU2039709279.SGD","BK1588","IE00B0JY6N72.USD","LU2476274308.USD","LU0326950275.SGD","159992","IE00B543WZ88.USD","09688","BK1191","LU0572944931.SGD","BK1141","LU0140636845.USD","01801","BK1610","LU0348784397.USD","02616","01177","BK1161","06160","02142","06978","03329","01877","BK1147","LU1951186391.HKD","02269","LU1969619763.USD","01093","09926"],"gpt_icon":0},{"id":"2590350406","title":"每日卖空追踪 | 中国生物制药 12月08日卖空量成交418.9万股,卖空比例为6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590350406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590350406?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182618,"startTime":"0","endTime":"0","summary":"中国生物制药北京时间12月08日,跌0.88%,卖空量成交418.9万股,较上一交易日减少31.69%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081632419531088e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081632419531088e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1521","BK1515","HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","01177","BK1589"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinobiopharm.com","stockEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0515},{"period":"3month","weight":-0.1937},{"period":"6month","weight":0.2556},{"period":"1year","weight":1.0309},{"period":"ytd","weight":1.0437}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国生物制药有限公司是一家主要从事制药业务的投资控股公司。该公司通过三个分部运营。中药现代制剂及西药分部主要从事生产、销售及配销中药现代制剂及西药产品业务。投资分部主要从事长期投资业务。其他分部主要从事相关医疗及医院业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.409091,"avgChangeRate":0.005246},{"month":2,"riseRate":0.681818,"avgChangeRate":0.063302},{"month":3,"riseRate":0.590909,"avgChangeRate":0.048254},{"month":4,"riseRate":0.5,"avgChangeRate":0.025891},{"month":5,"riseRate":0.727273,"avgChangeRate":0.043347},{"month":6,"riseRate":0.363636,"avgChangeRate":0.00957},{"month":7,"riseRate":0.636364,"avgChangeRate":0.047691},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.010062},{"month":9,"riseRate":0.409091,"avgChangeRate":-0.015174},{"month":10,"riseRate":0.545455,"avgChangeRate":0.025184},{"month":11,"riseRate":0.5,"avgChangeRate":0.066781},{"month":12,"riseRate":0.409091,"avgChangeRate":-0.010009}],"exchange":"SEHK","name":"中国生物制药","nameEN":"SINO BIOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国生物制药,01177,中国生物制药股票,中国生物制药股票老虎,中国生物制药股票老虎国际,中国生物制药行情,中国生物制药股票行情,中国生物制药股价,中国生物制药股市,中国生物制药股票价格,中国生物制药股票交易,中国生物制药股票购买,中国生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}